requiring intubation and mechanical ventilation. The recruited subjects were separated into three 48 different groups: smokers with CB and COPD (COPD, n=18), smokers with CB but without COPD 49 (S, n=8) and patients without CB and without COPD (C, n=10) . 50
Results. In mini-BAL of COPD group, Foxp3 and IP-10 were significantly reduced while TLR4 51 was significantly increased in comparison to C. TLR4 was also increased in mini-BAL of S. In 52 COPD peripheral blood, Foxp3 was reduced in comparison to C but no significant differences were 53 observed for TLR4 and for IP-10. No significant differences were observed for IL-8 concentrations 54
in the mini-BAL and in the blood of the recruited patients. The mini-BAL TLR4 expression 55 correlated with the Clinical Infective Pulmonary Score. 56
Conclusions.
In exacerbated COPD patients with respiratory failure, lung and systemic reduced 57 immune regulatory events (low Foxp3 expression) and lung increased innate immunity responses 58 (high TLR4 expression) occur. These events may contribute to the increased inflammatory events 59 leading to respiratory failure. 60 61 F o r P e e r R e v i e w O n l y INTRODUCTION 62 Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, is associated with 63 pulmonary and extra-pulmonary clinical manifestations and includes different clinically relevant 64 subtypes (1). One of the COPD subtypes is characterized by chronic bronchitis (CB). CB is a risk 65 factor for accelerated lung function decline in COPD, increased hospitalization, and increased 66 mortality (2). 67
Cigarette smoke represents the most important risk factor for CB (3). Chronic oxidative stress of 68 cigarette smoking induces mucus secretion and the increased mucus viscosity renders the airways 69 susceptible to bacterial infections, a hallmark of CB (3). 70
A key component of the innate immunity and of the innate defence mechanisms against infections 71 is represented by the toll like receptor (TLR) family (4) . 72
A recent hypothesis regarding COPD pathogenesis suggests as "step 1 of the disease" the activation 73 of innate responses by injured tissue components (5). Products derived from epithelial cell injury 74 can act as ligands for TLR4 and TLR2, thus amplifying inflammatory responses within the airways. 75
Cigarette smoke is able to increase the expression of TLR4 and to orientate the activation of TLR4 76 toward an increased release of IL-8 and a reduced release of interferon gamma-induced protein 10 77 (IP-10) in bronchial epithelial cells (6) . 78
In the airways of COPD patients mechanically ventilated due to acute respiratory failure, there is an 79 increased expression of TLR4 and an increased chemotactic activity toward neutrophils but a 80 reduced concentration of IP-10 with a reduced chemotactic activity toward lymphocytes (7). The 81 increased airway inflammation in the airways of COPD patients may also be sustained by the 82 impairment of immune regulatory events and in particular may be linked to the reduced expression 83 of the forkhead box P3 (Foxp3), a transcription factor crucially involved in T regulatory activities. 84 COPD patients have, in small airways, decreased numbers of Foxp3 positive cells that negatively 85 correlate with airflow obstruction (8) (9). Although COPD is associated with lung and systemic 86 F o r P e e r R e v i e w O n l y inflammation, it is unknown whether the alteration in the innate and immune regulatory events 87 observed in the airways of COPD patients are also present in the systemic compartment. 88
The objectives of this study were to investigate the immune regulatory events and the inflammatory 89 and the host defence responses in the airways and in the systemic compartment of COPD patients 90 with CB. Exacerbated COPD patients who experienced an acute respiratory failure requiring 91 endotracheal intubation and mechanical ventilation were compared to patients requiring also 92 intubation and mechanical ventilation but without COPD and without CB. In the recruited patients 93 the expression of TLR4, the expression of Foxp3 and the release of specific chemokines (IP-10 and 94 IL-8) were investigated. 95 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
MATERIALS AND METHODS 97

Patient population 98
This study was conducted at the ICU of the Department of Anestesiology, Reanimation and 99
Emergency of the University of Palermo, Italy. Local ethic committee permission and informed 100 written consent from either the patient or closest relatives were obtained. The patients were 101 classified into the following groups: 1) subjects without smoking history, without history of 102 previous CB or chronic pulmonary diseases including asthma and COPD and with acute respiratory 103 failure upon surgery for abdominal or thoracic aneurysm, (Controls =C; n=10); 2) smoking subjects 104 (>15 pack-year) with CB, without COPD and with acute respiratory failure upon surgery for 105 abdominal or thoracic aneurysm (S; n=8); 3) smoking subjects (>15 pack-year) with CB with 106 COPD (GOLD-1-2) and with acute respiratory failure upon treatment failure of an acute 107 exacerbation (COPD; n=18). The COPD patients fulfilled the diagnostic criteria of COPD (10) with 108 a post-bronchodilator obstruction (FEV 1 < 80% predicted, and FEV 1 /FVC ratio < 70%). Patients 109 with x-ray or clinical evidence of sepsis or pneumonia at the time of mini-bronchoalveolar lavage 110 (mini-BAL) collection were not included. CB were defined on the basis of symptoms and in 111 particular productive cough lasting more than three months in more than two years. All recruited 112 subjects required mechanical ventilation and underwent therapy with antibiotics and systemic 113 corticosteroids (no significantly different doses among the patients included in the three groups). 114
The antibiotics were adjusted to cover any identified pathogens on the basis of antibiograms. COPD 115 patients, before COPD exacerbation, were undergoing therapy with bronchodilators but not with 116 corticosteroids. Exacerbations were defined as previously reported (10) and were treated with 117 antibiotics and systemic corticosteroids. At the ICU admission, data for Clinical Pulmonary 118
Infective Score (CPIS), the simplified Acute Physiology Score (SAPS II) and sepsis-related organ 119 failure assessment (SOFA) were collected from each recruited patient. Paired mini-BAL and blood 120 samples were collected from all participants. Microbiology of mini-BAL was also assessed. Distal lung fluid samples (mini-BAL) were obtained using BAL Cath system (by Kimberly Clark) 123 within 1 h from the intubation. The protected catheter was blindly advanced through the 124 endotracheal tube until it was wedged into a distal airway and aliquots of 10 ml of sterile 0.9% 125 NaCl were instilled and gently suctioned (recovered volume about 70% of the instilled volume). 126
Mini-BAL samples were filtered through a sterile gauze and then centrifuged at 1300 rpm for 10 127 min to separate cells from supernatants. Total and differential (diff-quick staining) cell counts were 128 assessed. The cell fraction was used for immunocytochemistry and western blot experiments. The 129 supernatants were assessed for cytokine levels. 130
Blood samples 131
Blood samples (10 ml) were collected from C, S, COPD subjects and then processed for obtaining 132 plasma and peripheral blood mononuclear cells (PBMC). PBMC were isolated from blood s by 133
Ficoll-Hypaque (Pharmacia) gradient centrifugation. The cells were suspended in RPMI 1640 tissue 134 culture medium (Invitrogen Life Technologies) supplemented with 1% heat-inactivated FCS 135 (Invitrogen Life Technologies), 2 mM L-glutamine, 20 mM HEPES, 100 U/ml penicillin, 100 µg/ml 136 streptomycin, 5 x 10 -5 M 2-ME and 85 µg/ml gentamicin. Purity and viability were tested using 137 trypan blue exclusion. 138
Immunocytochemistry 139
The expression of TLR4 was evaluated using a rabbit polyclonal antibody (Santa Cruz 140 Biotechnology The expression of Foxp3 was evaluated by western blot analysis as previously described (11) with 146 minor modifications. 40 µg of total protein were loaded in the gel. All blots were probed using a 147 goat polyclonal antibody anti-Foxp3 (1:100) (Santa Cruz Biotechnology, Santa Cruz, CA). 148
Membranes were then stripped and incubated with goat polyclonal anti-ß-actin (Sigma) as 149 housekeeping protein to normalize differences in protein loading. Revelation was performed with an 150 enhanced chemioluminescence system (GE Healthcare, Chalfont St. Giles, UK) followed by 151 autoradiography. Negative controls were performed in the absence of primary antibody or including 152 an isotype control antibody. Data are expressed as densitometric arbitrary units by correction with 153 the density of the bands obtained for beta-actin. 154
Measurement of IL-8 and IP-10 155
The concentrations of IL-8 and IP-10 in plasma from C, S, CB-COPD subjects were determined by 156 an enzyme-linked immunosorbent assays (ELISA) following the manufacturer's instructions 157 (Quantikine; R&D Systems, Minneapolis, MN Demographic characteristics of the subjects. 167
The demographic characteristics of the three study groups are shown in Table 1. SAPS II and SOFA  168 scores revealed no significant differences in the recruited patients. The CPIS score was significantly 169 higher in COPD than in C (Table 1) . No significant differences for CPIS score were shown in S in 170 comparison to C and to COPD. The total and the differential cell counts of mini-BAL are shown in 171 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 This study explored whether lung and systemic inflammation occur concurrently and similarly in 213 patients with acute respiratory failure with and without CB or COPD. We demonstrated for the first 214 time that patients with both CB and COPD who underwent an acute exacerbation have a different 215 inflammatory profile (IP-10 levels) and a different alteration in the innate immune responses (TLR4 216 expression) in the airways and in the systemic compartment. Differently, in these patients a similar 217 alteration in the immune regulatory events (low Foxp3 expression) was observed in the airways and 218 in the systemic compartment. The novel aspects underlined by the present study are related to the 219 accurate selection of patients with a similar phenotype (CB) and a similar exposure to risk factor 220 (cigarette smoke) in order to limit the variability of the obtained results and to better identify the 221 role of the observed alterations in airway obstruction. Most of the studies report data from smoker 222 or COPD patients with different phenotypes. 223 CB is defined on the basis of chronic cough and sputum due to mucus hypersecretion and 224 histologically, it is characterised by airway inflammation, hypertrophy of submucosal mucus 225 secreting glands, and goblet cell hyperplasia (14). CB is a risk factor in COPD for accelerated lung 226 function decline, increased hospitalization, and increased mortality (2). In this regard it has been 227 demonstrated that the presence of CB may compromise the sterility of distal airway supporting the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Finally, the relevance of the observed alterations in the severity of the recruited patients was 286 assessed. Several commonly used scoring systems exist assessing the severity of the disease in 287 critically ill patients by predicting mortality. In the present study the recruited patients were 288
classified on the basis of their SOFA, SAPS II and CPIS score. The mortality in elderly patients 289 was higher than that of the younger patients and SAPS II (26) was an independent predictor of 290 mortality in elderly patients with sepsis (27). The SOFA score, widely used in many cardiac 291 surgical intensive units, is used for grading organ dysfunction or failing organ system (28) . 292
Prognostic relevance of the SOFA score in combination with inflammatory parameters was also 293 found in a recent study conducted by Zügel et al. (29) . The CPIS score is calculated on the basis of 294 points assigned for various signs and symptoms of pneumonia (eg, fever and extent of oxygenation 295 impairment) and a CPIS >6 may serve as a surrogate tool to facilitate the diagnosis of ventilator-296 associated pneumonia (30). In the present study, recruited patients have no significant different 297 SOFA or SAPS II scores and these scores did not correlate with any of the tested markers. The only 298 differences among the recruited patients were related to the CPIS score and CPIS score correlates 299 with TLR4 mini-BAL expression. Future studies on a larger cohort of patients are needed to clarify 300 whether the assessment of TLR4 expression in miniBAL may improve the predictive value of CPIS 301 to early identify patients with ventilator-associated pneumonia. 302
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